Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multigenome retroviral vector preparations and methods and systems for producing and using same

Multigenome retroviral vector preparations and methods and systems for producing and using same

US Patent 10179919 · Granted Jan 15, 2019

Estimated economic value: $1,203,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipid nanoparticle vaccine adjuvants and antigen delivery systems2022
Compositions comprising lentiviral vectors expressing IL-12 and methods of use t2022
Compositions comprising lentiviral vectors expressing IL-12 and methods of use t2022
Retroviral vector for the administration and expression of replicon RNA expressi2021
GLA monotherapy for use in cancer treatment2021
Lipid nanoparticle vaccine adjuvants and antigen delivery systems2020
Multigenome retroviral vector preparations and methods and systems for producing2020
Multigenome retroviral vector preparations and methods and systems for producing2020
GLA monotherapy for use in cancer treatment2019
GLA monotherapy for use in cancer treatment2015
GLA monotherapy for use in cancer treatment2015
Alphavirus replicon particles as immunological adjuvants2012